Federal Register / Vol. 72, No. 59 / Wednesday, March 28, 2007 / Notices 14599 

Place: National Institutes of Health, Two 

Democracy Plaza, 6707 Democracy 

Boulevard, Bethesda, MD 20892, (Telephone 

Conference Call). 

Contact Person: John F. Connaughton, PhD, 

Scientific Review Administrator, Review 

Branch, DEA, NIDDK, National Institutes of 

Health, Room 916, 6707 Democracy 

Boulevard, Bethesda, MD 20892–5452, (301) 

594–7797, 

connaughton@extra.niddk.nih.gov. 

This notice is being published less than 15 

days prior to the meeting due to the timing 

limitations imposed by the review and 

funding cycle. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.847, Diabetes, 

Endocrinology and Metabolic Research; 

93.848, Digestive Diseases and Nutrition 

Research; 93.849, Kidney Diseases, Urology 

and Hematology Research, National Institutes 

of Health, HHS) 

Dated: March 21, 2007. 

Jennifer Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 07–1518 Filed 3–27–07; 8:45 am] 

BILLING CODE 4140–01–M 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute on Drug Abuse; 

Notice of Closed Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. Appendix 2), notice 

is hereby given of the following 

meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The contract proposals and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the contract 

proposals, the disclose of which would 

constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute on 

Drug Abuse Special Emphasis Panel, 

Methods of Molecular Profiling of Tissues 

Using MALDI & Generalized Analytical 

Technique for the Metabolome. 

Date: March 30, 2007. 

Time: 11 a.m. to 12 p.m. 

Agenda: To review and evaluate contract 

proposals. 

Place: National Institutes of Health, 6101 

Executive Boulevard, Rockville, MD 20852, 

(Telephone Conference Call). 

Contact Person: Kristen V Huntley, PhD, 

Scientific Review Administrator, Office of 

Extramural Affairs, National Institute on 

Drug Abuse, NIH, DHHS, Room 220, MSC 

8401, 6101 Executive Boulevard, Bethesda, 

MD 20892–8401, 301–435–1433, 

huntleyk@mail.nih.gov. 

This notice is being published less than 15 

days prior to the meeting due to the timing 

limitations imposed by the review and 

funding cycle. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.279, Drug Abuse and 

Addiction Research Programs, National 

Institutes of Health, HHS) 

Dated: March 20, 2007. 

Jennifer Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 07–1520 Filed 3–27–07; 8:45 am] 

BILLING CODE 4140–01–M 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Library of Medicine; Notice of 

Closed Meetings 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. Appendix 2), notice 

is hereby given of the following 

meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Library of 

Medicine Special Emphasis Panel, Scholarly 

Works G13 Review. 

Date: June 4, 2007. 

Time: 9 a.m. to 4:30 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Embassy Suites at the Chevy Chase 

Pavilion, 4300 Military Road, NW., 

Washington, DC 20015. 

Contact Person: Zoe E. Huang, MD, Health 

Science Administrator, Division of 

Extramural Programs, National Library of 

Medicine, National Institutes of Health, 6705 

Rockledge Drive, Suite 301, MSC 7968, 

Bethesda, MD 20892–7968, 301–594–4937, 

huangz@mail.nih.gov. 

Name of Committee: National Library of 

Medicine Special Emphasis Panel, R21 

Review 

Date: July 11, 2007. 

Time: 8:30 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Embassy Suites at the Chevy Chase 

Pavilion, 4300 Military Road, NW., 

Washington, DC 20015. 

Contact Person: Zoe E. Huang, MD, Health 

Science Administrator, Division of 

Extramural Programs, National Library of 

Medicine, National Institutes of Health, 6705 

Rockledge Drive, Suite 301, MSC 7968, 

Bethesda, MD 20892–7968, 301–594–4937, 

huangz@mail.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.879, Medical Library 

Assistance, National Institutes of Health, 

HHS) 

Dated: March 21, 2007. 

Jennifer Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 07–1515 Filed 3–27–07; 8:45 am] 

BILLING CODE 4140–01–M 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Office of Biotechnology Activities, 

Office of Science Policy, Office of the 

Director; Notice of Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. Appendix 2), notice 

is hereby given of the meeting of the 

National Science Advisory Board for 

Biosecurity (NSABB). 

Under authority 42 U.S.C. 217a, 

Section 222 of the Public Health Service 

Act, as amended, the Department of 

Health and Human Services established 

NSABB to provide advice, guidance and 

leadership regarding Federal oversight 

of dual use research, defined as 

biological research with legitimate 

scientific purposes that could be 

misused to pose a biological threat to 

public health and/or national security. 

The meeting will be open to the 

public, however pre-registration is 

strongly recommended due to space 

limitations. Persons planning to attend 

should register online at http:// 

www.biosecurityboard.gov/meetings.asp 

or by calling Capital Consulting 

Corporation (Contact: Karen Brooks at 

301–468–6004, ext. 443. Individuals 

who plan to attend and need special 

assistance, such as sign language 

interpretation or other reasonable 

accommodations, should indicate these 

requirements upon registration. 

Name of Committee: National Science 

Advisory Board for Biosecurity. 

Date: April 19, 2007. 

Open: 8 a.m. to 6 p.m. 

Agenda: Presentations and discussions 

regarding: (1) Proposed strategies for 

oversight of life sciences research with dual 

use potential; (2) international dialogue on 

dual use research issues; (3) public 

comments; and (4) and other business of the 

Board. 


sroberts on PROD1PC70 with NOTICES
14600 Federal Register / Vol. 72, No. 59 / Wednesday, March 28, 2007 / Notices 

Place: The National Institutes of Health, 31 

Center Drive, Building 31, C Wing, 6th Floor, 

Rooms 6–10, Bethesda, Maryland 20892. 

Contact Person: Ronna Hill, NSABB 

Program Assistant, 6705 Rockledge Drive, 

Bethesda, Maryland 20892, (301) 496–9838. 

This meeting will also be webcast. The 

draft meeting agenda and other information 

about NSABB, including information about 

access to the webcast and pre-registration, 

will be available at http:// 

ww.biosecurityboard.gov/meetings.asp. 

Any member of the public interested in 

presenting oral comments at the meeting may 

notify the Contact Person listed on this notice 

at least 10 days in advance of the meeting. 

Interested individuals and representatives of 

an organization may submit a letter of intent, 

a brief description of the organization 

represented and a short description of the 

oral presentation. Only one representative of 

an organization may be allowed to present 

oral comments. Both printed and electronic 

copies are requested for the record. In 

addition, any interested person may file 

written comments with the committee. All 

written comments must be received by April 

2, 207 and should be sent via e-mail to 

nsabb@od.nih.gov with ‘‘NSABB Public 

Comment’’ as the subject line or by regular 

mail to 6705 Rockledge Drive, Suite 750, 

Bethesda, MD 20892, Attention Ronna Hill. 

The statement should include the name, 

address, telephone number and, when 

applicable, the business or professional 

affiliation of the interested person. 

In the interest of security, NIH has 

instituted stringent procedures for entrance 

onto the NIH campus. All visitor vehicles, 

including taxicabs, hotel, and airport shuttles 

will be inspected before being allowed on 

campus. Visitors will be asked to show one 

form of identification (for example, a 

government-issued photo ID’s driver’s 

license, or passport) and to state the purpose 

of their visit. 

Dated: March 20, 2007. 

Jennifer Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 07–1511 Filed 3–27–07; 8:45 am] 

BILLING CODE 4140–07–M 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Center for Scientific Review; Notice of 

Closed Meetings 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. Appendix 2), notice 

is hereby given of the following 

meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel, Small 

Business: Dentistry-Related. 

Date: April 12–13, 2007. 

Time: 8 a.m. to 9 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892, 

(Virtual Meeting). 

Contact Person: J. Terrell Hoffeld, DDS, 

PhD, Dental Officer, USPHS, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 4116, 

MSC 7816, Bethesda, MD 20892, (301) 435–

1781, th88q@nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel, Bridges to 

the Future. 

Date: May 16, 2007. 

Time: 8 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: The River Inn, 924 25th Street, NW., 

Washington, DC 20037. 

Contact Person: Cathleen L. Cooper, PhD, 

Scientific Review Administrator, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 4208, 

MSC 7812, Bethesda, MD 20892, (301) 435–

3566, cooperc@csr.nih.gov. 

Name of Committee: Oncological Sciences 

Integrated Review Group, Cancer Molecular 

Pathobiology Study Section. 

Date: May 24–25, 2007. 

Time: 8 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: DoubleTree Hotel, 1515 Rhode 

Island Avenue, Washington, DC 20005. 

Contact Person: Elaine Sierra-Rivera, PhD, 

Scientific Review Administrator, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 6184, 

MSC 7804, Bethesda, MD 20892, (301) 435–

1779, riverase@csr.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.306, Comparative Medicine; 

93.333, Clinical Research, 93.306, 93.333, 

93.337, 93.393–93.396, 93.837–93.844, 

93.846–93.878, 93.892, 93.893, National 

Institutes of Health, HHS) 

Dated: March 21, 2007. 

Jennifer Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 07–1502 Filed 3–27–07; 8:45 am] 

BILLING CODE 4140–01–M 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Center for Scientific Review; Notice of 

Closed Meetings 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. Appendix 2), notice 

is hereby given of the following 

meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel, AMCB 

Member Conflicts. 

Date: April 2, 2007. 

Time: 12 p.m. to 4 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892, 

(Telephone Conference Call). 

Contact Person: Eduardo A. Montalvo, 

PhD, Scientific Review Administrator, Center 

for Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 5212, 

MSC 7852, Bethesda, MD 20892, (301) 435–

1168, montalve@csr.nih.gov. 

This notice is being published less than 15 

days prior to the meeting due to the timing 

limitations imposed by the review and 

funding cycle. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel, The Global 

Infectious Disease Meeting. 

Date: April 10, 2007. 

Time: 8 a.m. to 6 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Georgetown Inn, 1310 Wisconsin 

Avenue, NW., Washington, DC 20007. 

Contact Person: Dan D. Gerendasy, PhD, 

Scientific Review Administrator, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 5132, 

MSC 7843, Bethesda, MD 20891, 301–594–

6830, gerendad@csr.nih.gov. 

This notice is being published less than 15 

days prior to the meeting due to the timing 

limitations imposed by the review and 

funding cycle. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.306, Comparative medicine; 

93.333, Clinical Research, 93.306, 93.333, 

93.337, 93.393–93.396, 93.837–93.844, 

93.846–93.878, 93.892, 93.893, National 

Institutes of Health, HHS) 


sroberts on PROD1PC70 with NOTICES